Brugada Flashcards
Neuro dd of Brugada
FA- freidrichs ataxia T-thiamine def D-dmd
What will u look for in CXR in Brugada pattern
Mediastinal mass compressing RVOT
Echo considerations in Brugada
RA- nil sp RV- RVMI,arvd, acute PE LA-nil sp LV-myocarditis Ao-dissection Pericardium-pericarditis, hemopericardium
ECG considerations in Brugada
RBBB.,LBBB,LVH,Early repolarisation
Long QT 3
Hyperkalemia,Hypercalcemia
Brugada is due to
Sodium channelopathy
Brugada sign is
Coved ST >2 mm in 2 or more of V1-3 with neg T wave i.e. Type 1 pattern is called Brugada sign
Brugada sign plus —- diagnoses Brugada syndrome
Clinical criteria
- VF or Polymorphic VT
- Family h/o of SCD less than 45
- Brugada sign in family members
- Inducible VT in EPS
- Syncope (likely due to tachyarrhythmia)
- Nocturnal agonal respiration
2005 consensus conference
Mean age of sudden death in Brugada
41 yrs
Type 3 Brugada pattern is
Less than 2 mm ST elevation
Leads used for Brugada diagnosis
V1-3
It’s V1& 2 only as per 2013 HRS Guidelines
Latest as of 2018 April
Non diagnostic Brugada patterns
Type 2 and 3
Right precordial leads are
V1-2
As per 2013 HRS Guidelines
Common feature of all 3 Brugada patterns
J point elevation of 2 mm or more
Not ST segment.
Preferred intercostal space for ECG in Brugada
2nd ICS
Type 1 ECG pattern with no clinical criteria is called
Idiopathic Brugada ECG pattern
Most controversial topic in Brugada
Value of EPS
Dec 2017 review for HRS Guidelines JACC- Doesn’t support EPS in most Asymptomatic Brugada pattern
Only drug which maybe useful in Brugada
Quinidine And Amiodarone
Two diseases caused by SCN5A mutations
Brugada and Lng QT3 syndrome
Both are autosomal dominant
When does Brugada and Long QT 3 manifest
Brugada in adulthood in males
Long QT3 usually in teenage years
Drugs increasing ST elevation in. Brugada
Beta blockers, Class I A and C
Drugs which increase ST elevation of Brugada but decreases arrythmogenicity in Long QT 3
Beta blockers
Drugs which increases arrythmogenicity in Brugada but reduces in Long QT 3
Class I A and C
Brugada pattern in ECG could be an early sub clinical manifestation of
ARVD
Brugada syndrome is functional abnormality in
Repolarisation
HRS ECG criteria which support diagnosis of Brugada syndrome in patient with brugada pattern
- First degree heart block
- AF
- Fragmented QRS
- ST/T alternans with LBBB ectopics in HOLTER
- Late potentials on SAE
- Absence of structural heart disease including ischemia–so..?TMT
- Some EP features
BLAST Fragmented QRS
How to differentiate Brugada from RBBB and athletes
At 40 ms of high take off the decrease in amplitude in Brugada is 4 mm or less
In RBBB and athletes it is much higher
Asymptomatic Brugada pattern what to do
Do nothing . Uptodate 06/2017
3 drugs which reduce arrhythmogenicity in Long QT3
Beta blockers ClassI A& C
Drugs which reduce arrhythmogenecity in Long QT3
Beta blockers, Class IA& C
These drugs increase ST elevation in Brugada
Drug given to induce Brugada
Class 1 anti arrhythmic drugs intravenous
Precautions for Asymptomatic Brugada who go for sports
Avoid dehydration / electrolyte depletion
Avoid fever/ heat exhaustion - treat With antipyretics early
Personal AED
Avoid large meals and excess Alcohol
ECG finding in Brugada
- Pseudo RBBB &
- ST elevation
In V1 and V2
Brugada was introduced as a clinical entity in
1992
Brugada causes death in
Young healthy adults
Less frequent in infants and children
Which guidelines suggested only 2 types of Brugada
2012 consensus report
Normal ECG recording amplitude
10mm per mV
Brugada syndrome is caused by ————-of———————in the —————-
Inactivation of Sodium channels in Right Ventricle
Difference between epsilon wave of ARVD and r’ of Brugada type 2
Epsilon wave is usually separated from the QRS
Also no clear ST elevation &
Symmetric negative T waves in V1-3
Epsilon wave in ARVD represents
Early after depolarizations
Epsilon wave is described as a
“Grassy knoll” after the QRS
Duration of the base of triangle of r’ 5mm from peak of r more than —— suggests Brugada type 2
> 160 ms
ECG DD of Type 2 Brugada
iRBBB, P.excavatum, ARVD, Athletes
Diagnostic criteria followed for Brugada is the
2013 HRS/EHRA/APHRS expert consensus statement
No of leads to diagnose Brugada as per 2013 Guidelines
ONE
V1 or V2
Using standard or superior lead placement.
ST elevation in Type 1 Brugada
2mm or more
At take off
Fragmented QRS means
Notching of QRS in presence of narrowQRS- may represent scar
The largest international registry of Brugada
SABRUS registry
Peak arrhythmic events in Brugada occurs between
38-48 years
Common drugs which may unmask Brugada
Beta blockers, Alcohol
Patients with Type 2 Brugada should undergo drug challenge if
Family history of SCD below 45 or
Family history of Brugada pattern Type 1
The high take off of ST segment in Brugada is due to
Abnormal repolarisation in the RVOT
Gene mutation in Brugada
SCN5A
The descend of ST at 40 ms in Brugada Type 1versus RBBB or Athletes
4 mm or less in Brugada while more in others
i.e slow descend in Brugada
Minimum ST elevation at lowest point in Brugada Type 2
0.5 mm
r’ takeoff is at least 2mm
T wave in Type 2 Brugada
Upright in V2
Variable in V1
2013 Guidelines on when to suspect Brugada syndrome in Type 1 pattern with ECG, Holter, SAECG, EP
BLAQ- Block- first degree AV block Left -axis deviation A-Atrial fibrillation Q- QRS Fragmented
Holter- ST-T alternans with LBBB ectopics
SAECG- done only if high index of suspicion- Late potentials seen
EP- not recommended: may be done if additional risk stratfn required. HV interval long, VRP less( Uptodate)
Clinical features other than ECG required for Brugada syndrome diagnosis
VAS F2E
V- VF/VT-Polymorphic
A- Agonal respiration (nocturnal)
S- Syncope
F-Family history- Death < 45; or Type1 pattern in first degree relative
EP- inducible VT
2005 consensus
Arrhythmic storm may be defined as
3 or more VT/VF in 24 hours
2013 consensus on arrhythmias
Drug to be used to suppress arrhythmic storm in BrS patients
Isoprenaline infusion
Also Quinidine
For Asymptomatic pts also Quinidine May be considered